-
1
-
-
0032576426
-
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group
-
Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-30.
-
(1998)
Lancet
, vol.352
, pp. 1725-1730
-
-
Mocroft, A.1
Vella, S.2
Benfield, T.L.3
-
2
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
-
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 1998; 338: 853-60.
-
(1998)
New Engl J Med
, vol.338
, pp. 853-860
-
-
Palella Jr, F.J.1
Delaney, K.M.2
Moorman, A.C.3
-
3
-
-
10744227881
-
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: The Swiss HIV Cohort Study
-
Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 2003; 163: 2187-95.
-
(2003)
Arch Intern Med
, vol.163
, pp. 2187-2195
-
-
Kaufmann, G.R.1
Perrin, L.2
Pantaleo, G.3
-
4
-
-
33845396491
-
A comparison of three highly active antiretroviral treatment strategies consisting of nonnucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): A long-term randomised trial
-
MacArthur RD, Novak RM, Peng G, et al. A comparison of three highly active antiretroviral treatment strategies consisting of nonnucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. Lancet 2006; 368: 2125-35.
-
(2006)
Lancet
, vol.368
, pp. 2125-2135
-
-
MacArthur, R.D.1
Novak, R.M.2
Peng, G.3
-
5
-
-
33846439783
-
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
-
Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis 2007; 44: 441-6.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 441-446
-
-
Moore, R.D.1
Keruly, J.C.2
-
6
-
-
2542496096
-
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
-
Garcia F, de Lazzari E, Plana M, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr 2004; 36: 702-13.
-
(2004)
J Acquir Immune Defic Syndr
, vol.36
, pp. 702-713
-
-
Garcia, F.1
de Lazzari, E.2
Plana, M.3
-
7
-
-
0041326880
-
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
-
Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003; 17: 1907-15.
-
(2003)
AIDS
, vol.17
, pp. 1907-1915
-
-
Hunt, P.W.1
Deeks, S.G.2
Rodriguez, B.3
-
8
-
-
34547478269
-
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: An observational cohort study
-
Mocroft A, Phillips AN, Gatell J, et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370: 407-13.
-
(2007)
Lancet
, vol.370
, pp. 407-413
-
-
Mocroft, A.1
Phillips, A.N.2
Gatell, J.3
-
9
-
-
0035362495
-
Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy
-
Tarwater PM, Margolick JB, Jin J, et al. Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 27: 168-75.
-
(2001)
J Acquir Immune Defic Syndr
, vol.27
, pp. 168-175
-
-
Tarwater, P.M.1
Margolick, J.B.2
Jin, J.3
-
10
-
-
37349126951
-
Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
-
Ferradini L, Laureillard D, Prak N, et al. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 2007; 21: 2293-301.
-
(2007)
AIDS
, vol.21
, pp. 2293-2301
-
-
Ferradini, L.1
Laureillard, D.2
Prak, N.3
-
11
-
-
17144373731
-
Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: Evidence of extended virologic and CD4+ cell count responses
-
Kabugo C, Bahendeka S, Mwebaze R, et al. Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr 2005; 38: 78-94.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 78-94
-
-
Kabugo, C.1
Bahendeka, S.2
Mwebaze, R.3
-
12
-
-
2142764446
-
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
-
Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-95:
-
(2004)
AIDS
, vol.18
, pp. 887-895
-
-
Coetzee, D.1
Hildebrand, K.2
Boulle, A.3
-
13
-
-
33750253231
-
Globil and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
-
Hemelaar J, Gouws E, Ghys PD, Osmanov, S. Globil and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 AIDS 2006; 20: W13-23.
-
(2006)
AIDS
, vol.20
-
-
Hemelaar, J.1
Gouws, E.2
Ghys, P.D.3
Osmanov, S.4
-
14
-
-
53349171968
-
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
-
Khanna N, Opravil M, Furrer H, et al. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clin Infect Dis 2008; 47: 1093-101.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1093-1101
-
-
Khanna, N.1
Opravil, M.2
Furrer, H.3
-
15
-
-
0032771054
-
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
-
Mezzaroma I, Carlesimo M, Pinter E, et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 1999; 13: 1187-93.
-
(1999)
AIDS
, vol.13
, pp. 1187-1193
-
-
Mezzaroma, I.1
Carlesimo, M.2
Pinter, E.3
-
16
-
-
0030868897
-
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
-
Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-6.
-
(1997)
Science
, vol.277
, pp. 112-116
-
-
Autran, B.1
Carcelain, G.2
Li, T.S.3
-
17
-
-
34250335089
-
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs
-
Le Moing V, Thiebaut R, Chene G, et al. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs. HIV Med 2007; 8: 156-63.
-
(2007)
HIV Med
, vol.8
, pp. 156-163
-
-
Le Moing, V.1
Thiebaut, R.2
Chene, G.3
-
18
-
-
50949090165
-
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases
-
Baker JV, Peng G, Rapkin J, et al. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr 2008; 48: 541-6.
-
(2008)
J Acquir Immune Defic Syndr
, vol.48
, pp. 541-546
-
-
Baker, J.V.1
Peng, G.2
Rapkin, J.3
-
19
-
-
0032771054
-
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
-
Mezzaroma I, Carlesimo M, Pinter E, et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 1999; 13: 1187-93.
-
(1999)
AIDS
, vol.13
, pp. 1187-1193
-
-
Mezzaroma, I.1
Carlesimo, M.2
Pinter, E.3
-
20
-
-
33745877595
-
Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART
-
Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev 2006; 8: 88-97.
-
(2006)
AIDS Rev
, vol.8
, pp. 88-97
-
-
Aiuti, F.1
Mezzaroma, I.2
-
21
-
-
33645775059
-
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
-
Lawn SD, Myer L. Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006; 6: 59.
-
(2006)
BMC Infect Dis
, vol.6
, pp. 59
-
-
Lawn, S.D.1
Myer, L.2
Bekker, L.G.3
Wood, R.4
-
22
-
-
38949104111
-
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV infected adults
-
Clumeck N, Pozniak A, Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV infected adults. HIV Med 2008; 9: 65-71.
-
(2008)
HIV Med
, vol.9
, pp. 65-71
-
-
Clumeck, N.1
Pozniak, A.2
Raffi, F.3
-
23
-
-
48949097660
-
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
-
Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300: 555-70.
-
(2008)
JAMA
, vol.300
, pp. 555-570
-
-
Hammer, S.M.1
Eron Jr, J.J.2
Reiss, P.3
-
24
-
-
68349125047
-
-
Cited January 31, 2009. Available from
-
Current situation analysis. Cited January 31, 2009. Available from http://www.unaids.org/en/CountryResponses/Countries/thailand.asp.
-
Current situation analysis
-
-
|